AIM ImmunoTech Presents at Virtual Investor Long COVID Event -…
OCALA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. AMERICAN (“AIM” or the “Company”), an immunopharmaceutical company focused on the discovery and development
Home » ImmunoTech
OCALA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. AMERICAN (“AIM” or the “Company”), an immunopharmaceutical company focused on the discovery and development
A new analysis from The Schiller Kessler Group of national mortality data has found that preventable injury claimed 197,449 American lives in 2024, an average
Traffic surrounding a major stadium event can begin hours before the first spectator enters the venue and continue well after the crowd has gone home.
Every business hits a ceiling determined not by market size, competitive dynamics, or capital availability — but by the number of hours its owner can